Picture of Surgery Partners logo

SGRY — Surgery Partners News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Surgery Partners misses Q3 revenue estimates, cuts FY forecast

Overview

Surgery Partners Q3 revenue up 6.6% but slightly missed analyst expectations

Adjusted EPS for Q3 missed analyst estimates

Adjusted EBITDA rose 6.1% to $136.4 mln, slightly below estimates

Outlook

Company revises full-year guidance due to softer volume and payor mix trends

Company expects full-year revenue between $3.275 bln and $3.30 bln

Company anticipates full-year Adjusted EBITDA between $535 mln and $540 mln

Result Drivers

ORTHOPEDIC PROCEDURES - Co cites strength in orthopedic procedures as a key driver of topline growth

VOLUME AND PAYOR MIX - Co notes softer volume and payor mix trends impacted performance

M&A PIPELINE - Co continues to evaluate M&A pipeline and portfolio optimization opportunities

Key Details

MetricBeat/MissActualConsensus Estimate
Q3 RevenueSlight Miss*$821.50 mln$822 mln (10 Analysts)
Q3 Adjusted EPSMiss$0.13$0.17 (11 Analysts)
Q3 Adjusted EBITDASlight Miss*$136.40 mln$137.30 mln (10 Analysts)
Q3 Adjusted EBITDA Margin16.60%
Q3 Operating Income$105.70 mln
Q3 Pretax Profit$30.80 mln
*Applies to a deviation of less than 1%; not applicable for per-share numbers. Analyst Coverage The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell" The average consensus recommendation for the healthcare facilities & services peer group is "buy" Wall Street's median 12-month price target for Surgery Partners Inc is $32.00, about 32.8% above its November 7 closing price of $21.50 The stock recently traded at 21 times the next 12-month earnings vs. a P/E of 22 three months ago Press Release: ID:nGNX8zsHfd For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Surgery Partners

See all news